American Society of Addiction Medicine
The Voice of Addiction Medicine
Submit your abstract for the 2016 Annual Conference now. Deadline is October 2!
Thirteen US Senators wrote a letter to the Secretary of Health and Human Services Sylvia M. Burwell requesting that she use her authority to lift the cap on the number of patients with an opioid use disorder a physician can treat at one time.
ASAM announces its participation in an AMA-convened task force to engage physicians and curb opioid abuse.
In this issue of ASAM’s official journal – Journal of Addiction Medicine – it’s found that for people who use cocaine, stopping or reducing cocaine use is associated with decreased levels of endothelin-1 (ET-1)—a protein that plays a key role in the development of coronary artery disease.
ASAM invites participation in a Twitter chat hosted by USA Today (@USATODAY) with health reporter Liz Szabo and CDC Director Tom Frieden this Thursday, July 9!
The Recovery Enhancement for Addiction Treatment (TREAT) Act would immediately expand patient access to effective addiction treatment by increasing the number of patients a provider is initially allowed to treat per year and removing the patient cap after one year for qualified physicians.
Upcoming Risk Evaluation and Mitigation Strategies (REMS) training for prescribers of Extended Release/Long Acting (ER/LA) Opioids provided in a 3 hour course.
Half online, half live course provides 8 hours of CME training for eligibility to obtain a DEA waiver to prescribe buprenorphine.
An 8 hour online DEA waiver training course.
A 4 hour online course that covers all SBIRT skills with simulated cases.
Our nationwide directory of addiction medicine professionals.
Deaths from opioid pain relievers exceed those from all illegal drugs.
© 2015 American Society of Addiction Medicine. All rights reserved.
4601 N. Park Avenue, Upper Arcade #101, Chevy Chase, MD 20815
Phone: 301-656-3920 |
Fax: 301-656-3815 |
Association Web Design by Matrix Group International, Inc.
Connect With Us